Nutraceuticals and functional foods in the prevention of mental disorders

Nutraceuticals and Functional Foods in Human Health and Disease Prevention

Volumn , Issue , 2015, Pages 255-268

  Keservani, Raj K ^a   Singh, Swati ^b   Singh, Virendra ^c   Kesharwani, Rajesh K ^d   Sharma, Anil K ^e  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

^b Sardar Bhagwan Singh Post Gratudate Institute of Biomedical Sciences & Research   (India)

^c Roorkee College of Engineering   (India)

^d National Institute of Technology   (India)

^e DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007584514     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b19308     Document Type: Chapter

References (97)

1. Beard, J. 1995. One person’s view of iron deficiency, development, and cognitive function. Am J Clin Nutr 62: 709-710.
2. Beard, J.L., J.R. Connor. 2003. Iron status and neural functioning. Annu Rev Nutr 23: 41-58.
3. Benowitz, N. 1990. Clinical pharmacology of caffeine. Ann Rev Med 41: 277-288.
4. Biesalski, H.K. 2001. Nutraceuticals: The link between nutrition and medicine. In: K. Kramer, P.P. Hoppe, L. Packer, eds. Nutraceuticals in Health and Disease Prevention. New York: Marcel Deckker Inc. pp. 1-26.
5. Blundell, J., D. Gumaste, R. Handley, L. Dye. 2003. Diet, behaviour and cognitive functions: A psychobiological view. Scand J Nutr 47(2): 85-91.
6. Boothby, L.A., P.L. Doering. 2005. Vitamin C and vitamin E for Alzheimer’s disase. Ann Pharmacother 39(2005): 2073-2080.
7. Botez, M. I. et al. 1993. Thiamine and folate treatment of chronic epileptic patients: A controlled study with the Wechsler IQ scale. Epilepsy Res 16: 157-163.
8. Chunhieng, M.T. (2003). Developpement de nouveaux aliments santé tropicale: application a la moix du Bresil Bertholettia excelsa et au fruit de Cambodge Morinda citrifolia. Ph.D thesis, INOL, France.
9. Cole, G.M., Q.L. Ma, S.A. Frautschy. 2009. Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids 81: 213-221.
10. Coppen, A., C. Bolander-Gouaille. 2005. Treatment of depression: Time to consider folic acid and vitamin B12. J Psychopharmacol 19(1): 59-65.
11. Das, U.N. 2008. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer’s disease but how and why? Prostaglandins Leukot Essent Fatty Acids 78: 11-19.
12. Dijsselbloem, N., W.V. Berghe, A.D. Naeyer, G. Haegeman. 2004. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections: Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem Pharmacol 68: 1171-1185.
13. Dillard, C.J., J.B. German. 2000. Review. Phytochemicals: Nutraceuticals and human health. J Sci Food Agric 80: 1744-1756.
14. Dworzariski, W. et al. 2009. Side effects of caffeine. Pol Merkurlekarski 27(161): 357-361.
15. Enig, M.G. 2000. Know Your Fats. Silver Spring, MD: Bethesda Press p. 64.
16. Erikson, J. 2006. Brain food: The real dish on nutrition and brain function. WisKids J. November/December. Retrieved from http://www.wccf.org/wkj/1106/story7.htm (accessed on May 12, 2014).
17. Evans-Olders, R., S. Eintracht, L.J. Hoffer. 2010. Metabolic origin of hypovitaminosis C in acutely hospitalized patients. Nutrition 26: 1070-1074.
18. Eyles, D.W. et al. 2005. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29(1): 21-30.
19. Farah, A. 2009. The role of l-methylfolate in depressive disorders. CNS Spectr 14(1 Suppl 2): 2-7.
20. Faraone, S.V. 1995. Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): Gender, psychiatric comorbidity, and maternal ADHD. J Abnorm Psychol 104: 334-345.
21. Faryadi, Q. 2012. The magnificent effect of magnesium to human health: A critical review. Int J Appl Sci Technol 2(3): 118-126.
22. Gardner, J.M. et al. 2005. Zinc supplementation and psychosocial stimulation: Effects on the development of undernourished Jamaican children. Am J Clin Nutr 82: 399-405.
23. Geir, B. 2013. The role of zinc and copper in autism spectrum disorders. Acta Neurobiol Exp 73: 225-236.
24. Gilbody, S, S. Lewis, T. Lightfoot. 2007. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: A HuGE review. Am J Epidemiol 165(1): 1-13.
25. Gleeson, M. 2012. Exercise, nutrition and immunity. In: P.C. Calder, P. Yaqoob, eds. Diet, Immunity and Inflammation. Cambridge, U.K.: Woodhead Publishing, pp. 652-685.
26. Grantham-Mcgregor, S., C. Ani. 2001. A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 131(2): 649S-666S.
27. Gu, Y., J.W. Nieves, Y. Stern, J.A. Luchsinger, N. Scarmeas. 2010. Food combination and Alzheimer’s disease risk. Arch Neurol 67(6): 1-6.
28. Hall, J.L. et al. 1989. Glucose enhancement of performance on memory tests in young and aged humans. Neuropsychologia 27: 1129-1138.
29. Hankey, G.J., J.W. Eikelboom. 1999. Homocysteine and vascular disease, Lancet 354: 407-413.
30. Hector, M., J.R. Burton. 1988. What are the psychiatric manifestations of vitamin B12 deficiency? J Am Geriatr Soc 36: 1105-1112.
31. Hoffer, L.J. 2012. Micronutrients and mental disorders. J Orthomol Med 27(4): 157-161.
32. Huang, E.P. 1997. Metal ions and synaptic transmission: Think zinc. Proc Natl Acad Sci USA 94: 13386-13387.
33. Institute of Medicine, Food and Nutrition Board (IMFNB). 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: The National Academy of Sciences.
34. Jeffery, D.R. 1999. Nutrition and diseases of the nervous system. In: M.E. Shils, J.A. Olson, M. Shike, A.C. Ross, eds. Modern Nutrition in Health and Disease. 9th edn. Baltimore, MD: Williams & Wilkins, pp. 1552-1553.
35. Jezova, D., R. Duncko, M. Lassanova, M. Kriska, F. Moncek. 2002. Reduction of rise in blood pressure and cortisol release during stress by Ginkgo biloba extract (EGb761) in healthy volunteers. J Phys Pharmacol 53(3): 337-348.
36. Jorde, R. et al. 2008. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: Randomized double blind trial. J Intern Med 264: 599-609.
37. Kalra, E.K. 2003. Nutraceutical-Definition and introduction. AAPS Pharm Sci 5: 1-2.
38. Kamiya, K., Y. Tanaka, H. Endang, M. Umar, T. Satake. 2004. Chemical constituents of Morinda citrifolia fruits inhibit copper-induced low-density lipoprotein oxidation, J Agric Food Chem 52: 5843-5848.
39. Kaplan, R.J., C.E. Greenwood, G. Winocur, T.M.S. Wolever. 2001. Dietary protein, carbohydrate and fat enhance memory performance in the healthy elderly. Am J Clin Nutr 74: 687-693.
40. Kaput, J., R.L. Rodriguez. 2004. Nutritional genomics: The next frontier in the postgenomic era. Physiol Genomics 16: 166-177.
41. Katz, D.L. 2001. Nutrition in Clinical Practice. New York: Lippincott, Williams, & Wilkins.
42. Kaur, J., M.S. Bhatia, P. Gautam. 2014. Role of dietary factors in psychiatry. Delhi Psychiatry J 17(2): 452-457.
43. Keservani, R.K., A.K. Sharma. 2014. Flavonoids: Emerging trends and potential health benefits. J Chin Pharm Sci 23(12): 815-822.
44. Keservani, R.K., R.K. Kesharwani, A.K. Sharma, N. Vyas, A. Chadoker. 2010b. Nutritional supplements: An overview. Int J Curr Pharm Rev Res 1: 59-75.
45. Keservani, R.K., R.K. Kesharwani, N. Vyas, S. Jain, R. Raghuvanshi, A.K. Sharma. 2010a. Nutraceutical and functional food as future food: A review. Der Pharmacia Lett 2: 106-116.
46. Khan, T.M. et al. 2011. Nutraceuticals use among the inhabitants of Penang, Malaysia. Int J Collab Res Int Med Public Health 3(5): 402-414.
47. Lambert, C. et al. 2004. Macronutrient considerations for the sport of bodybuilding. Sports Med 34: 317-327.
48. Le, B.P.L., M. Keiser, K.Z. Itil. 2000. A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb 761 in dementia. Dement Geriatr Cogn Disord 11(4): 230-237.
49. Lichtenstein, A.H. 2006. Dietary fat, carbohydrate, and protein: Effects on plasma lipoprotein patterns. J Lipid Res 47: 1661-1667.
50. Maes, M., E. Bosmans, E. Suy, C. Vandervorst, C. DeJonckheere, J. Raus. 1991. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 84: 379-386.
51. Mahoney, C.R. et al. 2005. The Acute Effects of Meals on Cognitive Performance. Boca Raton, FL: Taylor & Francis Group, LLC.
52. Maughan, R.J., J. Griffin. 2003. Caffeine ingestion and fluid balance: A review. J Hum Nutr Diet 16: 411-420.
53. McCann, J.C., B.N. Ames. 2008. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 22: 982-1001.
54. McCulley, K.S. 2007. Homocysteine, vitamins and vascular disease prevention. Am J Clin Nutr 86: S1563-S1568.
55. Menrad, K. 2003. Market and marketing of functional food in Europe. J Food Eng 56: 181-188.
56. Mills, J.L. 2000. Fortification of foods with folic acid: How much is enough? N Engl J Med 342: 1442-1445.
57. Morris, M.S., P.F. Jacques, I.H. Rosenberg, J. Selhub. 2007. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 85: 193-200.
58. Murray-Kolb, L.E., J.L. Beard. 2007. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 85: 778-787.
59. Naylor, G.J., A.H. Smith. 1981. Vanadium: A possible aetiological factor in manic depressive illness. Psychol Med 11: 249-256.
60. Nehlig, A. et al. 1992. Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic, and psychostimulant effects. Brain Res Rev 17(2): 139-170.
61. Nichenametla, S.N., T.G. Taruscio, D.L. Barney, J.H. Exon. 2006. A review of the effects and mechanism of polyphenolics in cancer. Crit Rev Food Sci Nutr 46: 161-183.
62. Oteri, A. et al. 2007. Intake of energy drinks in association with alcoholic beverages in cohort of students of the School of Medicine of the University of Messina. Alcohol Clin Exp Res 31(10): 1677-1809.
63. Oyama, Y., L. Chikahisa, T. Ueha, K. Kanemaru, K. Noda. 1996. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res. 712(2): 349-352.
64. Packer, L., S.U. Weber. 2001. The Role of Vitamin E in the Emerging Field of Nutraceuticals. New York: Marcel Dekker. pp. 27-43.
65. Parker, G. et al. 2006. Omega-3 fatty acids and mood disorders. Am J Psychiatry 163: 969-978.
66. Phillips, S. 2004. Protein requirements and supplementation in strength sports. Nutrition 20: 689-695.
67. Powers, H.J. 2003. Riboflavin (vitamin B-2) and health. Am J Clin Nutr 77(6): 1352-1360.
68. Prakash, D., N. Kumar. 2011. Cost effective natural antioxidants. In: R.R. Watson, J.K. Gerald, V.R. Preedy, eds. Nutrients, Dietary Supplements and Nutriceuticals. New York: Humana Press, Springer. pp. 163-188.
69. Prakash, D., R. Dhakarey, A. Mishra. 2004. Carotenoids: The phytochemicals of nutraceutical importance. Ind J Agric Biochem 17: 1-8.
70. Qureshi, A.A., W.A. Salser, R. Parmar, E.E. Emeson. 2001. Novel tocotrienols of rice bran inhibit atherosclerotic lesions in C57Bl/6 apoe-deficient mice. J Nutr 131: 2606-2618.
71. Ramsey, D., P.R. Muskin. 2013. Vitamin deficiencies and mental health: How are they linked. Curr Psychiatry 12(1): 37-44.
72. Rausch, R. 2013. Nutrition and academic performance in school-age children the relation to obesity and food insufficiency. J Nutr Food Sci 3(2): 1-3.
73. Roberfroid, M. B. 2002. Global view on functional foods: European perspectives. Br J Nutr. 88: S133-S138.
74. Samaniego-Vaesken, M.L., E. Alonso-Aperte, G. Varela-Moreiras. 2009. Elaboración de una base de datos del contenido en folatos de los alismentos: Fortificación voluntaria con acido folico en España. Nutr Hosp 24: 459-466.
75. Samaniego-Vaesken, M.L., E. Alonso-Aperte, G. Varela-Moreiras. 2010. Analysis and evaluation of voluntary folic acid fortification of breakfast cereals in the Spanish market. J Food Compos Anal 23: 419-423.
76. Segura, R., J. Ventura,. 1988. Effect of l-tryptophan supplementation on exercise performance. Int J Sports Med 9: 301-305.
77. Seifert, S. et al. 2011. Health effects of energy drinks on children, adolescents, and young adults. Pediatrics 127(3): 511-528.
78. Sembulingam, K., P. Sembulingam, A. Nanasivayam. 1997. Effect of Ocimum sanctum Linn on noise induced changes in plasma corticosterone level. Ind J Physiol Pharmacol 41(2): 139-143.
79. Shiveley, L.R., J.P. Connolly. 2000. Medical nutrition therapy for neurologic disorders. In: L.K. Mahan, S. Escott-Stump, eds. Krause’s Food, Nutrition, & Diet Therapy. 10th edn. New York: W. B. Saunders Company, pp. 935-969.
80. Smith, A.D., H. Refsum. 2009. Vitamin B12 and cognition in the elderly. Am J Clin Nutr 89: 707S-711S.
81. Sun, W., Q. Wang, B. Chen, J. Liu, H. Liu, W. Xu. 2008. γ-Tocotrienol-induced apoptosis in human gastric cancer SGC-7901 cells is associated with a suppression in mitogen-activated protein kinase signaling. Br J Nutr 99: 1247-1254.
82. Sydenstricker, V.P., H.M. Cleckley. 1941. The effect of nicotinic acid in stupor, lethargy and various other psychiatric disorders. Am J Psychiatry 98: 83-92.
83. Tangney, C.C. et al. 2009. Biochemical indicators of vitamin B12 and folate insuficiency and cognitive decline. Neurology 72: 361-367.
84. Tipton, K. et al. 2004. Ingestion of casein and whey proteins result in muscle anabolism after resistance exercise. Med Sci Sports Exerc 36: 2073-2081.
85. Tripathi, K.D. 2009. Essentials of Medical Pharmacology. New Delhi, India: Jaypee Brothers Medical Publishers (P) ltd.
86. Tu, J.B., H. Shafey, C. Van Dewetering. 1994. Iron deficiency in two adolescents with conduct, dysthymic and movement disorders. Can J Psychiatry 39: 371-375.
87. Vogel, T. et al. 2009. Homocysteine, vitamin B12, folate and cognitive functions: A systematic and critical review of the literature. Int J Clin Pract 63: 1061-1067.
88. Wang, M.Y. et al. 2002. Morinda citrifolia (Noni): A literature review and recent advances in Noni research. Acta Pharmacol Sin 23: 1127-1141.
89. Watts, D.L. 1988. The nutritional relationships of iron. J Orthomol Med 3(3): 110-116.
90. Weber, C.A., E.M. Ernst. 2006. Antioxidants, supplements, and Parkinson’s disease. Ann Pharmacother 40: 935-938.
91. Westermarck, T., E. Antila. 2000. Diet in relation to the nervous system. In: J.S. Garrow, W.P.T. James, A. Ralph, eds. Human Nutrition and Dietetics. 10th edn. New York: Churchill Livingstone, pp. 715-730.
92. Wilkins, C.H. et al. 2006. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 14: 1032-1040.
93. Williams, M. 2005. Dietary supplements and sports performance: Amino acids. J Int Soc Sports Nutr 2(2): 63-67.
94. Williams, M.H. 2005. Nutrition for Health, Fitness & Sports. Boston, MA: McGraw-Hill.
95. 2-mediated oxidative modification of human low density lipoproteins. Eur J Nutr. Epub April 15. DOI 10.1007/s00394-005-0546-y.
96. Zee, J. et al. 1991. Effect of storage conditions on the stability of vitamin C in various fruits and vegetables produced and consumed in Quebec. J Food Compos Anal 4: 77.
97. Zimmermann, M.B., J. Kohrle. 2002. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: Biochemistry and relevance to public health. Thyroid 12: 867-878.